abstract |
The invention provides a compound of formula I, where X, Y, Z, R and R are as described herein, as well as its salts, and the therapeutic use of these compounds for the treatment of disorders associated with RAF kinase activity. In addition, the invention relates to pharmaceutical compositions containing these compounds. |